Recent studies uncovered genetic polymorphisms in the promoter of MIF that are associated with the severity of carotid artery atherosclerosis34 and potentially cardiomyocyte response to ischemia35, and some polymorphisms show association to different aspects of cardiovascular disease, depending on the vascular bed affected36–38 or presence of additional risk factors39. Here, MIF is linked to cardiovascular disorder.